| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |